USA |PINK |USD
|Public Float||P/E Ratio||228.38|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||8.84%||Ex-Dividend Date||Mar 19, 2020|
|Held by Institutions||75.41%||IPO Date||-|
|Jun 21||Jun 20||Jun 19|
|Jun 21||Mar 21||Dec 20|
Abcam trades on the OTC Markets stock market in USA under the ticker symbol "ABCZF". Abcam’s stock symbol can also be displayed as "OTCMKTS:ABCZF".
Abcam (OTCMKTS:ABCZF) is owned by 75.41% institutional shareholders and by 8.84% insiders. The rest is owned by the public.
Explore More Details on Abcam's “Ownership” Section
Abcam's key executive team includes the following managers:
Abcam (OTCMKTS:ABCZF) is classified under the "Healthcare" sector and under the "Biotechnology" industry.
Currently the number of employees working for Abcam is 1,650.
Abcam (OTCMKTS:ABCZF) is headquartered in United Kingdom.
Abcam’s mailing address is Discovery Drive, Cambridge, United Kingdom, CB2 0AX.
The company’s phone number is 44 1223 696 000.